The Biosafety and Risk Management in Preparation and Processing of Cerebrospinal Fluid and Other Neurological Specimens With Potential Coronavirus Infection
The recent outbreak of coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2, has become a global threat. Due to neurological manifestations presented throughout the coronavirus disease process, the potential involvement of COVID-19 in central nervous system...
Main Authors: | Chien-Chin Chen, Pei-Chun Chiang, Tsung-Hsien Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2020.613552/full |
Similar Items
-
Comparison of cerebellomedullary and lumbar cerebrospinal fluid analysis in dogs with neurological disease
by: Rachel Lampe, et al.
Published: (2020-03-01) -
Cerebrospinal Fluid Findings in Six Dogs with Neurological Disease
by: Cecilia Gabriella DANCIU, et al.
Published: (2019-06-01) -
Editorial: New cerebrospinal fluid research to uncover mechanisms driving neurological and psychiatric diseases, volume II
by: Thomas Skripuletz, et al.
Published: (2023-12-01) -
A Case of Possible Motor-Sensory Symptoms Event Associated with SARS-Coronavirus-2
by: Sajjad Hoseinpour, et al.
Published: (2022-12-01) -
Cerebrospinal fluid analysis in 58 ruminants showing neurological disorders
by: Antônio Carlos L. Câmara, et al.
Published: (2020-07-01)